VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 55 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,569,000 | +190.6% | 81,968 | +42.7% | 0.00% | – |
| Q4 2018 | $540,000 | -81.6% | 57,425 | -62.9% | 0.00% | -100.0% |
| Q3 2018 | $2,932,000 | +84.9% | 154,924 | +90.8% | 0.00% | 0.0% |
| Q2 2018 | $1,586,000 | +131.5% | 81,185 | +122.5% | 0.00% | – |
| Q1 2018 | $685,000 | +13.0% | 36,482 | 0.0% | 0.00% | – |
| Q4 2017 | $606,000 | -21.1% | 36,482 | -2.2% | 0.00% | -100.0% |
| Q3 2017 | $768,000 | +129.9% | 37,295 | 0.0% | 0.00% | – |
| Q2 2017 | $334,000 | -24.4% | 37,295 | +11.8% | 0.00% | – |
| Q1 2017 | $442,000 | -8.7% | 33,356 | -12.2% | 0.00% | – |
| Q4 2016 | $484,000 | +3.4% | 37,978 | -2.5% | 0.00% | – |
| Q3 2016 | $468,000 | -7.7% | 38,936 | -15.6% | 0.00% | – |
| Q2 2016 | $507,000 | +382.9% | 46,106 | +283.0% | 0.00% | – |
| Q1 2016 | $105,000 | -60.2% | 12,039 | 0.0% | 0.00% | – |
| Q4 2015 | $264,000 | – | 12,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |